Bacteriophage Prevention of Antibiotic Resistance.

Diagnostics, Infectious Diseases.Company has developed patent-pending bacteriophages designed to increase the efficacy and extend the lifetime of antibiotics. Bacteriophages serve as biological agents that target bacteria and compromise their viability, and the company’s technology specifically inhibits the intracellular bacterial processes that enable their resistance to antibiotics. The phages only attack bacteria, rendering them safe for human use.

Click here for more information

The comments are closed.